Quidel Corp
NASDAQ:QDEL
Intrinsic Value
Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. [ Read More ]
The intrinsic value of one QDEL stock under the Base Case scenario is 72.287 USD. Compared to the current market price of 38.625 USD, Quidel Corp is Undervalued by 47%.
Valuation Backtest
Quidel Corp
Run backtest to discover the historical profit from buying and selling QDEL stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Quidel Corp
Current Assets | 1.3B |
Cash & Short-Term Investments | 167.3m |
Receivables | 303.3m |
Other Current Assets | 839.9m |
Non-Current Assets | 7.3B |
Long-Term Investments | 7.4m |
PP&E | 1.6B |
Intangibles | 5.4B |
Other Non-Current Assets | 205.5m |
Current Liabilities | 1B |
Accounts Payable | 294.8m |
Accrued Liabilities | 257.6m |
Other Current Liabilities | 454.2m |
Non-Current Liabilities | 2.6B |
Long-Term Debt | 2.3B |
Other Non-Current Liabilities | 275.8m |
Earnings Waterfall
Quidel Corp
Revenue
|
3B
USD
|
Cost of Revenue
|
-1.5B
USD
|
Gross Profit
|
1.5B
USD
|
Operating Expenses
|
-1.2B
USD
|
Operating Income
|
252.5m
USD
|
Other Expenses
|
-262.6m
USD
|
Net Income
|
-10.1m
USD
|
Free Cash Flow Analysis
Quidel Corp
What is Free Cash Flow?
QDEL Profitability Score
Profitability Due Diligence
Quidel Corp's profitability score is 69/100. The higher the profitability score, the more profitable the company is.
Score
Quidel Corp's profitability score is 69/100. The higher the profitability score, the more profitable the company is.
QDEL Solvency Score
Solvency Due Diligence
Quidel Corp's solvency score is 47/100. The higher the solvency score, the more solvent the company is.
Score
Quidel Corp's solvency score is 47/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
QDEL Price Targets Summary
Quidel Corp
According to Wall Street analysts, the average 1-year price target for QDEL is 84.252 USD with a low forecast of 50.5 USD and a high forecast of 165.9 USD.
Ownership
QDEL Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
QDEL Price
Quidel Corp
Average Annual Return | 28.51% |
Standard Deviation of Annual Returns | 88.44% |
Max Drawdown | -87% |
Market Capitalization | 2.6B USD |
Shares Outstanding | 67 300 000 |
Percentage of Shares Shorted | 4.94% |
QDEL News
Last Important Events
Quidel Corp
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Quidel Corp
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. The company is headquartered in San Diego, California and currently employs 1,600 full-time employees. The Company’s diagnostic testing solutions are separated into four product categories: rapid immunoassay, cardiometabolic immunoassay, molecular diagnostic solutions and specialized diagnostic solutions. Its diagnostic testing solutions under various brand names, including Quidel, QuickVue, QuickVue+, QVue, Sofia, Triage, Solana, Virena, MicroVue, Lyra, FreshCells, D3, FastPoint, ReadyCells, InflammaDry, AdenoPlus, ELVIRA, ELVIS, Thyretain and Savanna. The firm sells its products directly to end-users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers, as well as for individual, non-professional, over-the-counter (OTC) use.
Contact
IPO
Employees
Officers
The intrinsic value of one QDEL stock under the Base Case scenario is 72.287 USD.
Compared to the current market price of 38.625 USD, Quidel Corp is Undervalued by 47%.